「Tyrosine」の共起表現一覧(1語右で並び替え)
該当件数 : 233件
eucine, isoleucine) and aromatic (tryptophan, | tyrosine) amino acids. |
eucine, isoleucine) and aromatic (tryptophan, | tyrosine) amino acids. |
th activated aromatic rings, such as those of | tyrosine aminoacid. |
Tyrosine aminotransferase is the first in a series of | |
m of the transcription initiation site of the | tyrosine aminotransferase gene, for example. |
d gluconeogenesis - glucose-6-phosphatase and | tyrosine aminotransferase |
nemia is caused by a deficiency of the enzyme | tyrosine aminotransferase (EC 2.6.1.5), |
diiodotyrosine aminotransferase, halogenated | tyrosine aminotransferase, and halogenated tyrosine tr |
use include tyrase, phenylalanine deaminase, | tyrosine ammonia-lyase, L-tyrosine ammonia-lyase, phen |
( | tyrosine ammonia-lyases), and EC 4.3.1.26 |
of norepinephrine depends on the presence of | tyrosine, an amino acid found in proteins such as meat |
samples by the presence of cysteine, cystine, | tyrosine, and tryptophan side chains. |
transmitters; the synthesis and catabolism of | tyrosine; and the metabolism of microsome. |
o-Methyltyrosine or dansylalanine instead of | tyrosine, and by inserting genetically coded reporter |
valine, isoleucine, methionine, | tyrosine, and phenylalanine. |
This enzyme participates in phenylalanine, | tyrosine and tryptophan biosynthesis. |
This enzyme participates in | tyrosine and phenylalanine catabolism. |
This enzyme participates in phenylalanine, | tyrosine and tryptophan biosynthesis and two-component |
This enzyme participates in phenylalanine, | tyrosine and tryptophan biosynthesis and novobiocin bi |
This enzyme participates in phenylalanine, | tyrosine and tryptophan biosynthesis and aminoacyl-trn |
Three isomers of | tyrosine are known. |
n 1994, vWF was shown to be cleaved between a | tyrosine at position 1605 and a methionine at 1606 by |
o be provided by the carboxylic acid group of | tyrosine because tracking of radioactivity indicated t |
the turnip yellow mosaic virus genome whilst | tyrosine binds to the tRNA-like structure of the barle |
The amino acid | tyrosine contains a single phenolic ring that may be o |
In enzymology, a | tyrosine decarboxylase (EC 4.1.1.25) |
umarylacetoacetate inhibits previous steps in | tyrosine degradation leading to an accumulation of tyr |
e from the precursors mentioned above, namely | tyrosine, dopamine and their derivatives. |
rts on the solvent exposure of tryptophan and | tyrosine), far-ultraviolet circular dichroism (180-250 |
ingle amino acid, typically valine or another | tyrosine, form a short intra-molecular diphenylether c |
studies, which show an initially low rate of | tyrosine formation for full-length PheOH. |
However, the body can synthesise | tyrosine from phenylalanine, an essential amino acid. |
e results from the experiments indicated that | tyrosine, glycine, methionine, and acetate are the pri |
Tryptophan hydroxylase (TPH), | tyrosine hydroxylase (TH) and phenylalanine hydroxylas |
Tyrosine hydroxylase (TH) inhibitors like metirosine ( | |
shown to produce a uniform downregulation of | tyrosine hydroxylase protein and activity gene express |
Tyrosine hydroxylase | |
Alpha-methyl-p-tyrosine (AMPT) is a | tyrosine hydroxylase enzyme inhibitor. |
dopaminegenic, experiments measure the enzyme | tyrosine hydroxylase, since this enzyme is need to syn |
Analogously to phenylalanine hydroxylase and | tyrosine hydroxylase, this enzyme uses (6R)-L-erythro- |
ogy to the enzymes phenylalanine hydroxylase, | tyrosine hydroxylase, tryptophan hydroxylase and nitri |
within their 3'UTRs (rabbit lipoxygenase, rat | tyrosine hydroxylase, and human alpha(I)-collagen). |
As a competitive inhibitor of | tyrosine hydroxylase, it prevents the conversion of ty |
names in common use include pheochromocytoma | tyrosine hydroxylase-associated kinase, STK4, and tyro |
e and cardiac norepinephrine, and inactivates | tyrosine hydroxylase. |
esis of dopamine via inhibition of the enzyme | tyrosine hydroxylase. |
It is an inhibitor of the enzyme | tyrosine hydroxylase. |
he IE-ESR method was first used to detect the | tyrosine iminoxyl radical. |
has demonstrated that removal of a c-terminal | tyrosine increased the K+ current more than 10-fold. |
Tyrosine is not directly toxic to the liver or kidneys | |
Tyrosine is the precursor to dopamine, which in turn i | |
In addition, in the adrenal medulla, | tyrosine is converted into the catecholamine hormones |
In dopaminergic cells in the brain, | tyrosine is converted to levodopa by the enzyme tyrosi |
m of the hydrochloride monohydrate salt, is a | tyrosine kinase inhibitor. |
activated by G protein-coupled receptors and | tyrosine kinase receptors. |
HER2, a | tyrosine kinase receptor, is overexpressed by many can |
includes an SH2 domain, an SH3 domain, and a | tyrosine kinase domain. |
JAK3 encodes Janus kinase 3, a | tyrosine kinase that belongs to the Janus family. |
family has four members: JAK1, JAK2, JAK3 and | tyrosine kinase 2 (TYK2). |
are transmembrane proteins that act to block | tyrosine kinase signaling. |
ncodes a B-cell-specific scaffold protein and | tyrosine kinase substrate that promotes tyrosine phosp |
One such receptor-associated | tyrosine kinase is Janus kinase (JAK), many of whose e |
, a SH2 domain and in the C-terminal part the | tyrosine kinase domain. |
Neratinib (HKI-272) is a | tyrosine kinase inhibitor under investigation for the |
This gene encodes a member of the | tyrosine kinase and, more specifically, the Janus kina |
Other example of | tyrosine kinase receptors include the insulin receptor |
The similarity of the proteins includes the | tyrosine kinase domains and extends amino-terminal to |
This protein belongs to a subfamily of | tyrosine kinase receptors with a homology region to th |
Tyrosine kinase with immunoglobulin-like and EGF-like | |
a consequence of agonist stimulation of both | tyrosine kinase and G protein-coupled receptors. |
kine receptors is typically associated with a | tyrosine kinase belonging to the Janus kinase (JAK) fa |
zartinib (AC220) is a small molecule receptor | tyrosine kinase inhibitor that is currently under deve |
Tyrosine kinase receptors, including the IGF-1 recepto | |
sequences reveal that ALK is a novel receptor | tyrosine kinase having a putative transmembrane domain |
L, encodes an unregulated, cytoplasm-targeted | tyrosine kinase that allows the cells to proliferate w |
ll receives the LIN-3 signal via the receptor | tyrosine kinase LET-23 (P5.p and P7.p also receive LIN |
Tyrosine kinase growth factor receptors activate mitog | |
C-src | tyrosine kinase has been shown to interact with YTHDC1 |
EC 2.7.12.1) is a kinase that can act as both | tyrosine kinase and serine/threonine kinase. |
tracellular transduction of receptor-mediated | tyrosine kinase activators. |
The RET proto-oncogene encodes a receptor | tyrosine kinase for members of the glial cell line-der |
l motility, and morphogenesis by activating a | tyrosine kinase signaling cascade after binding to the |
nsmembrane-spanning region, and a cytoplasmic | tyrosine kinase domain. |
It encodes a protein with a | tyrosine kinase domain at the N-terminal end and a pro |
f and instead associate with the TYRO protein | tyrosine kinase binding protein to transduce activatin |
and neratinib, afatinib is a next generation | tyrosine kinase inhibitor (TKI) that irreversibly inhi |
This protein has been shown to bind | tyrosine kinase TYK2, and thus may mediate the signali |
Tir is also a receptor | tyrosine kinase (RTK) that initiates its intimate adhe |
astic lymphoma kinase (ALK) also known as ALK | tyrosine kinase receptor or CD246 (cluster of differen |
potent and selective multi-targeted receptor | tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, VEGFR-3 |
in patients with mutations of CD135 (FMS-like | tyrosine kinase 3 receptor). |
th Arp2/3 is cortactin, which appears to link | tyrosine kinase signalling to cytoskeletal reorganizat |
For example, the oncogenic form of the src | tyrosine kinase is not active and fails to transform c |
c membrane-spanning segment and a cytoplasmic | tyrosine kinase domain. |
emonstrated to express FLT1 (VEGFR1) receptor | tyrosine kinase which was functionally required for ef |
International RTK consortium - The Receptor | Tyrosine Kinase (RTK) Networks Consortium is an organi |
ly stimulate cellular responses by binding to | tyrosine kinase receptors (the VEGFRs) on the cell sur |
to treatment with imatinib (Gleevec), another | tyrosine kinase inhibitor currently used as a first-li |
the TCR by recruiting an enzyme, known as the | tyrosine kinase lck, which is essential for activating |
The | tyrosine kinase activity, in turn, initiates a signal |
tory cofactor NHE-RF2 (NHERF-2) also known as | tyrosine kinase activator protein 1 (TKA-1) or SRY-int |
C-src | tyrosine kinase |
It is a | tyrosine kinase inhibitor, being developed by AstraZen |
NGF binds to high-affinity | tyrosine kinase receptor TrkA. |
It belongs to the large class of | tyrosine kinase receptors. |
Crenolanib is a | tyrosine kinase inhibitor that acts by specifically in |
of epidermal growth factor receptor's (EGFR) | tyrosine kinase domain. |
ABL2 is a cytoplasmic | tyrosine kinase which is closely related to but distin |
Tyrosine kinase activity mediates the GC-C signaling p | |
(also known as AG013736) is a small molecule | tyrosine kinase inhibitor under development by Pfizer. |
Lck (or lymphocyte-specific protein | tyrosine kinase) is a protein that is found inside spe |
ert domain receptor (KDR, a type III receptor | tyrosine kinase) also known as vascular endothelial gr |
reatest sequence similarity to LTK (leukocyte | tyrosine kinase). |
C-src | tyrosine kinase, also known as CSK, is a human protein |
4 residue on human leukocyte-specific protein | tyrosine kinase, which acts as a negative regulatory s |
latelet-derived growth factor receptor PDGFR) | tyrosine kinase, inhibiting both PDGFRA and PDGFRB at |
The BCR-ABL transcript encodes a | tyrosine kinase, which activates mediators of the cell |
kinases, G-protein coupled receptor kinases, | tyrosine kinase, and cytomegalovirus pUL97 protein. |
-Met/Hepatocyte Growth Factor receptor (HGFR) | tyrosine kinase, which is involved in the oncogenesis |
Receptor | tyrosine kinase, as in fibroblast growth factor recept |
Lck is a | tyrosine kinase, which phosphorylates tyrosine residue |
um levels of PGF and sFlt-1 (soluble fms-like | tyrosine kinase-1, also known as soluble VEGF receptor |
volved in the negative regulation of receptor | tyrosine kinase-coupled signaling processes. |
G13 is also essential for receptor | tyrosine kinase-induced migration of fibroblast and en |
k" or signal to one another, such as Receptor | tyrosine kinase. |
1 (acidic fibroblast growth factor)-activated | tyrosine kinase. |
K3, HDAC3, Serum response factor and Bruton's | tyrosine kinase. |
been shown to interact with E2F1 and Bruton's | tyrosine kinase. |
ass IA PI 3-kinases are activated by receptor | tyrosine kinases (RTKs). |
Tyrosine kinases recruited to a receptor following hor | |
riminate between even closely related protein | tyrosine kinases such as EGFR and its close relative H |
kinases act on both serine and threonine, the | tyrosine kinases act on tyrosine, and a number (dual-s |
ough G protein-coupled receptors and receptor | tyrosine kinases stimulate this hydrolysis. |
t, forming the largest sub-family of receptor | tyrosine kinases (RTKs). |
osphorylated after activation of cell surface | tyrosine kinases such as the epidermal growth factor r |
Growth factors bind to receptor | tyrosine kinases resulting in the polymerization of ac |
s gene is phosphorylated by ZAP70/SYK protein | tyrosine kinases following activation of the T-cell an |
Numerous tyrphostins/TKIs aiming at various | tyrosine kinases have been generated by the originator |
ortactin is activated via phosphorylation, by | tyrosine kinases or serine/threonine kinases, in respo |
Da) is activated by receptor and non-receptor | tyrosine kinases due to the presence of two SH2 and a |
ated signaling, including integrins, receptor | tyrosine kinases (RTKs), cytokine receptors (JAK/STATs |
Receptor | tyrosine kinases (RTKs) play a key role in the communi |
tinib selectively inhibits class III receptor | tyrosine kinases, including FMS-related tyrosine kinas |
-rich domain of Frizzled and several receptor | tyrosine kinases, which have roles in development, inc |
Together with | tyrosine kinases, PTPs regulate the phosphorylation st |
These are receptor | tyrosine kinases, so named because they mediate cell s |
Lyn is a member of the Src family of protein | tyrosine kinases, which is mainly expressed in hematop |
G-protein subunits, receptor and non-receptor | tyrosine kinases, endothelial nitric oxide synthase (e |
The tie receptors are | tyrosine kinases, so named because they mediate cell s |
(TKI) is a pharmaceutical drug that inhibits | tyrosine kinases, enzymes responsible for the activati |
pite less study and understanding compared to | tyrosine kinases. |
diverse proteins, including several receptor | tyrosine kinases. |
wth factor receptor (EGFR) family of receptor | tyrosine kinases. |
lar endothelial growth factor (VEGF) receptor | tyrosine kinases. |
family of four structurally related receptor | tyrosine kinases. |
RTK class III is a class of receptor | tyrosine kinases. |
eptor is part of the large family of receptor | tyrosine kinases. |
ligands of the Tie family of protein receptor | tyrosine kinases. |
gand that binds to the Eph-family of receptor | tyrosine kinases. |
ors used in treating cancer are inhibitors of | tyrosine kinases. |
This enzyme participates in | tyrosine metabolism and alkaloid biosynthesis. |
This enzyme participates in | tyrosine metabolism and cyanoamino acid metabolism. |
This enzyme participates in | tyrosine metabolism and phenylalanine metabolism. |
This enzyme participates in | tyrosine metabolism and nitrogen metabolism. |
enzyme participates in 5 metabolic pathways: | tyrosine metabolism, phenylalanine metabolism, nitroge |
ysis / gluconeogenesis, histidine metabolism, | tyrosine metabolism, phenylalanine metabolism, and met |
d threonine metabolism, histidine metabolism, | tyrosine metabolism, phenylalanine metabolism, tryptop |
6 metabolic pathways: methionine metabolism, | tyrosine metabolism, phenylalanine metabolism, phenyla |
n 5 metabolic pathways: histidine metabolism, | tyrosine metabolism, phenylalanine metabolism, phenyla |
This enzyme participates in | tyrosine metabolism. |
Catecholamine hormones produced from | tyrosine metabolism. |
This enzyme participates in | tyrosine metabolism.. |
One | tyrosine molecule is metabolised to dopamine which con |
(S)-norcoclaurine is derived from two | tyrosine molecules after decarboxylation. |
Nitrotyrosine is a product of | tyrosine nitration mediated by reactive nitrogen speci |
mate which can then be used in phenylalanine, | tyrosine or tryptophan biosynthesis. |
"Xxx" is either an aromatic (phenylalanine, | tyrosine) or a branched aliphatic (valine, isoleucine) |
e III because of the possible accumulation of | tyrosine or other intermediaries. |
Mescaline can be synthesized from | tyrosine or a hydroxylated phenylalanine. |
In enzymology, a | tyrosine phenol-lyase (EC 4.1.99.2) is an enzyme that |
the biosynthesis of the aromatic amino acids | tyrosine, phenylalanine, and tryptophan. |
e is a member of the dual specificity protein | tyrosine phosphatase family. |
Links to all 107 members of the protein | tyrosine phosphatase family can be found in the templa |
to Saccharomyces cerevisiae Cdc14, a protein | tyrosine phosphatase involved in the exit of cell mito |
well as the pro-diabetic target human protein | tyrosine phosphatase 1B (h-PTP 1B), which explain at l |
unctions as an acid phosphatase and a protein | tyrosine phosphatase by hydrolyzing protein tyrosine p |
Receptor | tyrosine phosphatase is a type of Enzyme-linked recept |
It has been shown that new protein | tyrosine phosphatase (PTP) activity for EPPase. |
of the Saccharomyces cerevisiae YVH1 protein | tyrosine phosphatase. |
phorylation by serine/threonine phosphatases, | tyrosine phosphatases, or dual-specificity phosphatase |
Upon binding, IL-12R-β2 becomes | tyrosine phosphorylated and provides binding sites for |
s of other proteins, and its SH2 domain binds | tyrosine phosphorylated sequences. |
ucture of the Shc SH2 domain Complexed with a | Tyrosine phosphorylated Peptide from the T-cell Recept |
The | tyrosine phosphorylation of Trask is tightly regulated |
He is well-known for discovering that | tyrosine phosphorylation is a fundamental mechanism fo |
The | tyrosine phosphorylation of CDCP1 in cultured cells oc |
ns, including RhoA-mediated contractility and | tyrosine phosphorylation in response to adhesion. |
and a cytoplasmic tail containing a potential | tyrosine phosphorylation site that may bind SH2. |
It stimulates | tyrosine phosphorylation processes including the Jak2/ |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると 検索履歴を保存できる! 語彙力診断の実施回数増加! |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると 検索履歴を保存できる! 語彙力診断の実施回数増加! |